These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
115 related articles for article (PubMed ID: 26440098)
1. Expansion of polyalanine tracts in the QA domain may play a critical role in the clavicular development of cleidocranial dysplasia. Wu LZ; Xu XY; Liu YF; Ge X; Wang XJ J Genet; 2015 Sep; 94(3):551-3. PubMed ID: 26440098 [No Abstract] [Full Text] [Related]
2. Biology of RUNX2 and Cleidocranial Dysplasia. Cohen MM J Craniofac Surg; 2013 Jan; 24(1):130-3. PubMed ID: 23348269 [TBL] [Abstract][Full Text] [Related]
3. The cleidocranial dysplasia-related R131G mutation in the Runt-related transcription factor RUNX2 disrupts binding to DNA but not CBF-beta. Han MS; Kim HJ; Wee HJ; Lim KE; Park NR; Bae SC; van Wijnen AJ; Stein JL; Lian JB; Stein GS; Choi JY J Cell Biochem; 2010 May; 110(1):97-103. PubMed ID: 20225274 [TBL] [Abstract][Full Text] [Related]
5. Four novel RUNX2 mutations including a splice donor site result in the cleidocranial dysplasia phenotype. Kim HJ; Nam SH; Kim HJ; Park HS; Ryoo HM; Kim SY; Cho TJ; Kim SG; Bae SC; Kim IS; Stein JL; van Wijnen AJ; Stein GS; Lian JB; Choi JY J Cell Physiol; 2006 Apr; 207(1):114-22. PubMed ID: 16270353 [TBL] [Abstract][Full Text] [Related]
6. Cleidocranial dysplasia with severe parietal bone dysplasia: C-terminal RUNX2 mutations. Cunningham ML; Seto ML; Hing AV; Bull MJ; Hopkin RJ; Leppig KA Birth Defects Res A Clin Mol Teratol; 2006 Feb; 76(2):78-85. PubMed ID: 16463420 [TBL] [Abstract][Full Text] [Related]
7. Cleidocranial dysplasia in a Polish population: high frequency of the R193X mutation. Kisiel BM; Kostrzewa G; Wlasienko P; Kruczek A; Gajdulewicz M; Maciejak D; Wisniewska M; Ploski R; Korniszewski L Clin Genet; 2006 Aug; 70(2):167-9. PubMed ID: 16879201 [No Abstract] [Full Text] [Related]
8. Cleidocranial dysplasia: Clinical, endocrinologic and molecular findings in 15 patients from 11 families. Dinçsoy Bir F; Dinçkan N; Güven Y; Baş F; Altunoğlu U; Kuvvetli SS; Poyrazoğlu Ş; Toksoy G; Kayserili H; Uyguner ZO Eur J Med Genet; 2017 Mar; 60(3):163-168. PubMed ID: 28027977 [TBL] [Abstract][Full Text] [Related]
9. [Clinical and molecular study in a family with cleidocranial dysplasia]. Callea M; Fattori F; Bertini ES; Yavuz I; Bellacchio E; Avendaño A; Araque D; Lacruz-Rengel MA; Da Silva G; Cammarata-Scalisi F Arch Argent Pediatr; 2017 Dec; 115(6):e440-e444. PubMed ID: 29087131 [TBL] [Abstract][Full Text] [Related]
11. A novel RUNX2 mutation in exon 8, G462X, in a patient with Cleidocranial Dysplasia. Jung YJ; Bae HS; Ryoo HM; Baek SH J Cell Biochem; 2018 Jan; 119(1):1152-1162. PubMed ID: 28703881 [TBL] [Abstract][Full Text] [Related]
12. Classical cleidocranial dysplasia in an adult, due to a novel frameshift pathogenic variant in RUNX2. Hebbar M; Girisha KM; Shukla A BMJ Case Rep; 2016 May; 2016():. PubMed ID: 27177937 [TBL] [Abstract][Full Text] [Related]
13. Clarification of data reported in "cleidocranial dysplasia: molecular genetic analysis and phenotypic-based description of a Middle European patient group" (AJMG 139A:78-85). Baumert U; Golan I; Redlich M; Aknin JJ; Muessig D Am J Med Genet A; 2006 May; 140(9):1030. PubMed ID: 16575894 [No Abstract] [Full Text] [Related]
14. Cleidocranial dysplasia plus vascular anomalies with 6p21.2 microdeletion spanning RUNX2 and VEGF. Izumi K; Yahagi N; Fujii Y; Higuchi M; Kosaki R; Naito Y; Nishimura G; Hosokai N; Takahashi T; Kosaki K Am J Med Genet A; 2006 Feb; 140(4):398-401. PubMed ID: 16419134 [No Abstract] [Full Text] [Related]